Zydus Lifesciences up nearly 3% after WHO approval for typhoid vaccine

October 23, 2024
Uncategorized

Zydus Lifesciences’ shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, making it eligible for UN agency procurement.

Zydus Lifesciences up nearly 3% after WHO approval for typhoid vaccine

Leave a ReplyCancel Reply

Petronet LNG signs 5-year regasification deal with ONGC, 1-year RLNG pact with Mahanagar Gas

Infosys ties up with Cursor to set up AI software engineering CoE

Maruti Suzuki Q3 Preview: Healthy volumes, SUVs to boost margins; revenue to grow double-digits

Vishal Mega Mart Q3 FY26 profit jumps 19%, revenue up 17% as store expansion, festive demand drive growth

Bikaji Foods Q3 Results | Net profit more than doubles to ₹62.6 cr, margins swell